信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·2023年11月第一周创新药周报(附小专题PARP1靶点研发概况)2023-11-7 18:57:05
·江中药业:控股子公司药品拟中选第九批全国药品集采2023-11-7 18:52:18
·第九批国家药品集采看点解读:41种药品采购成功 覆盖多个治疗类别2023-11-7 18:29:23
·IPO动态:海纳医药拟在深交所创业板上市募资8.5亿元2023-11-7 18:25:49
·科伦药业:四款产品拟中标全国药品集采2023-11-7 16:20:14
·沃华医药实控人被留置调查 公司称不影响生产经营2023-11-7 16:04:01
·天宇股份:子公司产品拟中选全国药品集采2023-11-7 15:59:27
·海翔药业:公司产品伏格列波糖片拟中标全国药品集采2023-11-7 15:14:29
·医药与健康护理行业周报:上海市人民政府办公厅发布《上海市加快合成生物创新策源打造高端生物制造产业集群行动方案(20232025年)》2023-11-7 15:12:27
·双鹭药业:公司三款产品拟中标全国药品集采2023-11-7 15:12:18
·医药健康行业研究:第九批集采平均降幅58%,腾笼换鸟更看创新2023-11-7 12:36:45
·医药行业行业研究:诺和诺德&礼来三季度GLP1板块持续高增长,司美格鲁肽国内单季销售额超16亿2023-11-7 11:04:29
·CRO概念震荡拉升 太龙药业涨停2023-11-7 10:09:42
·海特生物:注射用磷酸特地唑胺拟中选全国药品集采2023-11-7 9:37:06
·义翘神州:暂无用于临床治疗的减肥药产品2023-11-7 9:15:52
·“减肥神药”火爆全球,这些A股药企也在抢滩…谁能成为“药王”?2023-11-7 8:55:20
·新型减肥药成市场蓝海 药企纷纷抢滩布局2023-11-7 3:13:04
·股票行情快报:科伦药业(002422)11月6日主力资金净买入810.90万元2023-11-6 22:56:00
·广济药业:收到恩替卡韦《化学原料药上市申请批准通知书》2023-11-6 22:43:25
·医药生物行业周报:业绩短期放缓,政策逐渐转暖2023-11-6 22:26:46

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]